In vivo, SOGA1 and PDK4 knockdown both weakened overexpression of METTL116 elevated tumor growth, as reflected by tumor size (Fig. 8C), volume (Fig. 8D), and weight (Fig. 8E). Here, PDK4 is linked to neoplasm.